Two Sigma Securities’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Two Sigma Securities’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,598	Closed	-$300K	–	3621
2023 Q2	$347K	Buy	+1,598	New	+$342K	0.01%	1743

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Two Sigma Securities's KRTX Position: Q3 2023 in Review

Two Sigma Securities sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 1,598 shares — an estimated $300K sold.

Two Sigma Securities first reported a position in KRTX in Q2 2023 and held it in 1 quarter. The position peaked at $347K in Q2 2023. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

Two Sigma Securities reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Securities sold 1,598 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $300K.
Two Sigma Securities first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Two Sigma Securities's Karuna Therapeutics, Inc. Common Stock position peaked at $347K in Q2 2023.
256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.